arrow-left  #sun-pharmaceutical

Image not found
     
  • 26 February, 2024 |
  •  
  • 12:43 PM

The Mohali facility has been under USFDA scrutiny, and corrective actions were directed by the regulator.

Read More

More News

ALL #sun-pharmaceutical
Image not found
  • The Mohali facility has been under USFDA scrutiny, and corrective actions were directed by the regulator.
  • |
  • IIFL News Service |
  • 26 February, 2024 |
  • 12:12 AM
Image not found
  • Recommendation: Buy; Target price: ₹1625
  • |
  • IIFL News Service |
  • 14 February, 2024 |
  • 11:55 PM
Image not found
  • Recommendation: Buy; Target price: ₹1625
  • |
  • IIFL News Service |
  • 02 February, 2024 |
  • 11:37 PM
Image not found
  • Taro Pharma's operating income for the third quarter was $15.83 million, compared to $1.3 million in the corresponding quarter of the previous fiscal, with margins at 10.8%
  • |
  • IIFL News Service |
  • 29 January, 2024 |
  • 11:32 PM
ad IconAd Image